Clinical Trial Update: A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on ALN-PCSSC in subjects with elevated LDL cholesterol (hypercholesterolemia); the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• ALN-PCSSC

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED